Open AccessBelumosudil: A Rising Star for the Management of Chronic Graft-Versus-Host Disease and the First FDA-Approved ROCK2 Inhibitor
Author(s) -
Tony Kurian,
Frederick L. Locke
Publication year - 2021
Publication title -
the hematologist
Language(s) - English
Resource type - Journals
ISSN - 1551-8779
DOI - 10.1182/hem.v18.6.202168
Subject(s) - rock2 , host (biology) , disease , star (game theory) , medicine , graft versus host disease , biology , rho associated protein kinase , genetics , astrophysics , signal transduction , physics